분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2016-02-01 15:17:34 , Hit : 837
 CRISPR Fixes Stem Cells Harboring Blindness-Causing Defect

GEN News
Jan 27, 2016
  
Skin cells from a patient with X-linked retinitis pigmentosa were transformed into induced pluripotent stem cells, and the blindness-causing point mutation in the RPGR gene was corrected using CRISPR/Cas9. [Vinit Mahajan, University of Iowa Health Care]  

Marking yet another CRISPR-related first, scientists have replaced a defective gene associated with a sensory disease in stem cells that were derived from a patient’s tissue. The disease, retinitis pigmentosa (RP), is an inherited condition that degrades the retina and leads to blindness. A patient with the disease supplied a skin sample that was used to generate the stem cells, which were manipulated by means of the CRISPR/Cas9 gene-editing system.

CRISPR/Cas9, which zeroed in on a single disease-causing mutation in the RGPR gene, was able to make the necessary correction in 13% of the stem cells. This correction rate, according to the Columbia University and University of Iowa scientists who announced the results, is indicative of a practical approach—albeit one that still needs work. The Columbia/Iowa team added that they are working to show that their technique does not introduce any unintended genetic modifications in human cells, and that the corrected cells are safe for transplantation.

While the scientists freely acknowledge that their technique needs additional development before any cures are possible, they basked in the success of having accomplished a difficult genetic fix. The RGPR mutation that needed to be repaired sits in a highly repetitive sequence of the gene where it can be tricky to discriminate one region from another. In fact, it was not clear that CRISPR/Cas9 would be able to home in on and correct the point mutation.

The scientists described their work January 27 in the journal Scientific Reports in an article entitled “Precision Medicine: Genetic Repair of Retinitis Pigmentosa in Patient-Derived Stem Cells.”

“Fibroblasts cultured from a skin-punch biopsy of an XLRP patient were transduced to produce [induced pluripotent stem cells (iPSCs)] carrying the patient’s c.3070G > T mutation,” the authors wrote. “The iPSCs were transduced with CRISPR guide RNAs, Cas9 endonuclease, and a donor homology template. Despite the gene’s repetitive and GC-rich sequences, 13% of RPGR gene copies showed mutation correction and conversion to the wild-type allele.”

The authors asserted that theirs was the first report of CRISPR/Cas9 being used to correct a pathogenic mutation in iPSCs derived from a patient with photoreceptor degeneration. This proof-of-concept finding, they added, supports the development of personalized iPSC-based transplantation therapies for retinal disease.

The authors also emphasized that because the corrections are made in cells derived from the patient's own tissue, doctors can retransplant the cells with fewer fears of rejection by the immune system. Previous clinical trials have shown that generating retinal cells from embryonic stem cells and using them for transplantation is a safe and potentially effective procedure.

Recently, another group has used CRISPR to ablate a disease-causing mutation in rats with retinitis pigmentosa. Going forward, the first clinical use of CRISPR could be for treating an eye disease because compared to other body parts, the eye is easy to access for surgery, readily accepts new tissue, and can be noninvasively monitored.







1207   Outsourcing Gene Editing to the Public-Online Game Challenges Players to Design CRISPR On/Off Switch  이성욱 2017/09/05 798
1206   Resistance to HIV Engineered Via CRISPR  이성욱 2017/08/07 805
1205   Cancer Onset May Be Caused by Immune System Fighting Viruses  이성욱 2017/08/25 808
1204   Uncovering Functions of Circular RNAs  이성욱 2017/08/14 812
1203   [바이오토픽] 드디어 올 것이 왔다: CRISPR, 생존가능 인간배아의 질병초래 유전자 교정 성공  이성욱 2017/08/03 813
1202   Zika Update  이성욱 2016/03/15 817
1201   CRISPR Corrects RNA-based Disease Defects  이성욱 2017/08/14 823
1200   “유전자 치료 법률 금지 한국 유일” vs “생명체 설계도 바꾸는 건 문제”  이성욱 2017/08/28 826
  CRISPR Fixes Stem Cells Harboring Blindness-Causing Defect  이성욱 2016/02/01 837
1198   First In Vivo Human Genome Editing to Be Tested in New Clinical Trial  이성욱 2017/05/18 844
1197   유전자치료제 '인보사' 연골재생 입증못해도 허가받은 까닭  이성욱 2017/07/14 850
1196   [바이오토픽] FDA 자문위원회, CAR-T(chimeric antigen receptor T cell) 승인 만장일치로 권고  이성욱 2017/07/14 852
1195   First In Vivo Function Found for Animal Circular RNA  이성욱 2017/08/14 853
1194   ‘단세포 인공생명체’ 눈앞에 성큼  이성욱 2017/03/11 859
1193   Revisiting CAR T-Cells for Treating HIV Shows Promise  이성욱 2016/07/19 863
1192   Engineered Human Liver Tissue Grows in Mice  이성욱 2017/07/25 864
1191   Using Gene Editing to Delete HIV from Human T Cells  이성욱 2016/03/23 867
1190   CRISPR Can Tag RNA  이성욱 2016/03/26 870
1189   독감바이러스의 ‘RNA 도둑질’  이성욱 2017/05/08 873
1188   유전자 가위로 바이러스 제거한 '청정 돼지' 나왔다  이성욱 2017/08/24 873

[1][2][3] 4 [5][6][7][8][9][10]..[64] [다음 10개]
 

Copyright 1999-2023 Zeroboard / skin by ROBIN